Interpretation of the key points of "Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"
- VernacularTitle:《全球癌症统计数据2022》要点解读
- Author:
Peiyu WANG
1
,
2
;
Qi HUANG
3
;
Shaodong WANG
2
,
4
;
Xiankai CHEN
5
;
Ruixiang ZHANG
5
;
Jia ZHAO
3
;
Mantang QIU
2
,
4
;
Yin LI
5
;
Xiangnan LI
3
Author Information
1. 1. Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, P. R. China 2. Thoracic Oncology Institute/Department of Thoracic Surgery, Peking University People'
2. s Hospital, Beijing, 100044, P. R. China
3. Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, P. R. China
4. Thoracic Oncology Institute/Department of Thoracic Surgery, Peking University People'
5. Department of Thoracic Surgical Oncology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Cancer
- Publication Type:Journal Article
- Keywords:
Cancer;
global cancer burden;
cancer incidence;
cancer mortality
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(07):933-954
- CountryChina
- Language:Chinese
-
Abstract:
"Global cancer statistics 2022" based on the latest GLOBCAN data from the International Agency for Research on Cancer (IARC) was recently released, providing a systematic analysis of the incidence and mortality of 36 types of cancer across 185 countries worldwide. The international burden of cancer is expected to continue to increase over the next 30 years, posing a severe public health and social challenge for many countries, including China. This article offers a key point interpretation of the "Global cancer statistics 2022", focusing on the evolution of cancer epidemiology and future development trends. The aim is to broaden the international perspective on cancer prevention and treatment, with the hope of providing reference and guidance for cancer prevention and treatment efforts in our country.
